ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has announced the composition of its Board of Directors and Board committees. The Board includes both executive and non-executive Directors, alongside independent non-executive Directors. Additionally, the company outlined the members and chairpersons of its three main Board committees: Audit, Remuneration, and Nomination.
For further insights into HK:1541 stock, check out TipRanks’ Stock Analysis page.